JPRN-UMIN000014058已完成4 期
Study for the effect of visceral fat reduction by SGLT2 inhibitor Ipragliglozinin patients with type 2 diabetes - Visceral fat reduction by SGLT2 inhibitor Ipragliflozin
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) hypersensitivity to Ipragliflozin, 2) unstable diabetic retinopathy, 3) severe hepatic, renal, or heart dysfunction, 4) pregnancy, 5) patients who are inadequate to enter this study due to the other reasons by physician's judgments
研究者
相似试验
已完成
不适用
Study on abdominal visceral fat reducing action by indigestible dextrin-containing tea beverage - Randomized placebo-controlled double-blind parallel group comparison studyot applicableJPRN-UMIN000032508Coca-Cola (Japan) Company, limited Matsutani Chemical Industry co.,ltd140
招募中
Unknown
Intervention study to verify the effect of the changes in intestinal bacteria by intake of tea catechin and inulin on visceral fat reductioJPRN-jRCTs021230004Mikami Tatsuya114
已完成
Unknown
Validation study on body fat-reducing effects by a long-term test-drink ingestioHealthy male/female adultsJPRN-UMIN000049522CPCC Company Limited80
已完成
不适用
Examination study on abdominal visceral fat reducing action by functional food intake -Randomized placebo-controlled double-blind parallel group comparison studyot applicableJPRN-UMIN000026291Maruzen Pharmaceuticals Co., Ltd.70
已完成
不适用
The differential effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic indices and adipocytokinesObesityISRCTN79667806Yonsei University College of Medicine (South Korea)52